3 more vaccine developers seek PH clinical trials
Three more coronavirus vaccine developers have applied for clinical trials in the Philippines.
The Department of Science and Technology's Task Group on Vaccine Evaluation and Selection received applications from West China Hospital and Sichuan University, Shenzhen Kangtai Biological Products Co., and Eubiologics Co. Ltd.
Evaluation is ongoing for the first two applicants while Eubiologics is still completing requirements.
Janssen and Clover Biopharmaceuticals' clinical trials are currently underway, with Sinovac's trial awaiting protocol amendment submission.
This story was generated by AI to help you understand the key points. For more detailed coverage, please see the news articles from trusted media outlets below.